These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 805232)

  • 1. Inhibition of Pseudomonas burn wound infection by mafenide dry foam.
    Catania PN; King JC
    J Pharm Sci; 1975 Feb; 64(2):339-40. PubMed ID: 805232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
    Catania PN; King JC
    J Pharm Sci; 1975 Mar; 64(3):457-8. PubMed ID: 807702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
    Rode H; de Wet PM; Davies MR; Cywes S
    Prog Pediatr Surg; 1981; 14():189-208. PubMed ID: 7221007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
    Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
    Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a prototype therapeutic system for prolonged, continuous topical delivery of homosulfanilamide in the management of Pseudomonas burn wound sepsis.
    Vistnes LM; Schmitt EE; Ksander GA; Rose EH; Balkenhol WJ; Coleman CL
    Surgery; 1976 Jun; 79(6):690-6. PubMed ID: 1273754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mafenide hydrochloride and mafenide acetate in spray and ointment forms as topical therapy of C. perfringens contaminated massive wounds: experimental study.
    Mendelson JA; Pratt HJ; Amato JJ; Lieberman MK; Hamm TE; Gruber RP; Brinkley FB; Heitkamp DH; Healy MJ
    J Trauma; 1970 Dec; 10(12):1132-44. PubMed ID: 4320694
    [No Abstract]   [Full Text] [Related]  

  • 7. The "Sulfamylon sandwich"--a laminated mafenide-saline dressing.
    Buehler PK; Reading GP; Jacoby FG; Harrison HN
    Ann Plast Surg; 1980 Aug; 5(2):157-9. PubMed ID: 7004316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mafenide acetate concentrations and bacteriostasis in experimental burn wounds treated with a three-layered laminated mafenide-saline dressing.
    Falcone PA; Harrison HN; Sowemimo GO; Reading GP
    Ann Plast Surg; 1980 Oct; 5(4):266-9. PubMed ID: 6985504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns.
    Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H
    Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract]   [Full Text] [Related]  

  • 11. 2.5% Mafenide Acetate: A Cost-Effective Alternative to the 5% Solution for Burn Wounds.
    Afshari A; Nguyen L; Kahn SA; Summitt B
    J Burn Care Res; 2017; 38(1):e42-e47. PubMed ID: 27606553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine Is a Critical Substrate for the Pathogenesis of
    Everett J; Turner K; Cai Q; Gordon V; Whiteley M; Rumbaugh K
    mBio; 2017 Mar; 8(2):. PubMed ID: 28292986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns.
    Cooper RA; Halas E; Molan PC
    J Burn Care Rehabil; 2002; 23(6):366-70. PubMed ID: 12432313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of topical povidone-iodine ointment in experimental burn wound sepsis.
    Robson MC; Schaerf RH; Krizek TJ
    Plast Reconstr Surg; 1974 Sep; 54(3):328-34. PubMed ID: 4211994
    [No Abstract]   [Full Text] [Related]  

  • 15. Current approach to prevention and treatment of Pseudomonas aeruginosa infections in burned patients.
    Pruitt BA; Lindberg RB; McManus WF; Mason AD
    Rev Infect Dis; 1983; 5 Suppl 5():S889-97. PubMed ID: 6361962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetic acid used for the elimination of Pseudomonas aeruginosa from burn and soft tissue wounds.
    Sloss JM; Cumberland N; Milner SM
    J R Army Med Corps; 1993 Jun; 139(2):49-51. PubMed ID: 8355236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of antiinfection effect of topical "moist ointment" in burn wound infection].
    Yang Y; Ge S; Huo Z
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1994 Jan; 10(1):11-4. PubMed ID: 8087681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of formulated Zoush ointment against wound infection and gene expression of virulence factors Pseudomonas aeruginosa.
    Meskini M; Esmaeili D
    BMC Complement Altern Med; 2018 Jun; 18(1):185. PubMed ID: 29903005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
    Ziółkowski G; Dudzińska G; Sakiel S
    Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlling methicillin resistant Staphyloccocus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial.
    Martineau L; Davis SC; Peng HT; Hung A
    J Invest Surg; 2007; 20(4):217-27. PubMed ID: 17710602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.